Literature DB >> 28573642

Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein-Barr virus-associated oral squamous cell carcinomas.

Ati Burassakarn1,2, Chamsai Pientong1,2, Nuchsupha Sunthamala3,2, Jureeporn Chuerduangphui1,2, Patravoot Vatanasapt4,2, Natcha Patarapadungkit5,2, Bunkerd Kongyingyoes6, Tipaya Ekalaksananan7,8.   

Abstract

The etiology of oral carcinogenesis appears to be multifactorial. There is emerging evidence of the presence of Epstein-Barr virus (EBV) in epithelial oral squamous cell carcinoma (OSCC), but an association of EBV with oral carcinogenesis has not yet been established. Although epigenetic alterations, such as aberrant DNA methylation, are known to contribute to the pathogenesis of oral cancer, the relationship of such alterations with EBV infection is little known. This study aimed to investigate the association between EBV infection and promoter methylation patterns of tumor-associated genes in OSCC tissues. A total of 165 of formalin-fixed paraffin-embedded OSCC tissues were studied (68 of EBV positive and 97 of EBV negative). The promoter methylation patterns were investigated for four tumor-associated genes, E-cadherin, p16 INK4a , p14 ARF , and MGMT, by using methylation-specific polymerase chain reaction (MSP). The frequencies of gene promoter hypermethylation in all cases were 47.3% for E-cadherin, 92.7% for p16 INK4a , 74.5% for p14 ARF , and 35.8% for MGMT. Interestingly, most of the analyzed gene promoters were more frequently hypermethylated in EBV-positive than EBV-negative cases, in particular the E-cadherin (56/22) and MGMT (38/21) gene promoters (p < 0.05). Concomitantly, hypermethylation of multiple gene promoters (≥3) was encountered more frequently in EBV-positive samples. Hypermethylation of the E-cadherin promoter associated with EBV was more frequently observed in moderately and poorly differentiated OSCC tissues. These results indicate that epigenetic changes frequently occur in OSCCs and may partly be induced by EBV infection, therefore, EBV may involve in development and progression of the OSCCs.

Entities:  

Keywords:  Epigenetic changes; Epstein–Barr virus; Oral squamous cell carcinoma; Promoter methylation

Mesh:

Substances:

Year:  2017        PMID: 28573642     DOI: 10.1007/s12032-017-0983-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  46 in total

1.  The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.

Authors:  Chi-Neu Tsai; Chia-Lung Tsai; Ka-Po Tse; Hwan-You Chang; Yu-Sun Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

2.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Authors:  M Sanchez-Cespedes; M Esteller; L Wu; H Nawroz-Danish; G H Yoo; W M Koch; J Jen; J G Herman; D Sidransky
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

3.  Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.

Authors:  Kue Peng Lim; Hamid Sharifah; Shin Hin Lau; Soo-Hwang Teo; Sok Ching Cheong
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

Review 4.  Oral squamous cell carcinoma overview.

Authors:  Crispian Scully; Jose Bagan
Journal:  Oral Oncol       Date:  2009-02-26       Impact factor: 5.337

5.  Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use.

Authors:  Jamshid Jalouli; Salah O Ibrahim; Dipak Sapkota; Miranda M Jalouli; Endre N Vasstrand; Jan M Hirsch; Per-Anders Larsson
Journal:  J Oral Pathol Med       Date:  2010-07-02       Impact factor: 4.253

Review 6.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

7.  Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.

Authors:  Elin Ringström; Edward Peters; Masayuki Hasegawa; Marshall Posner; Mei Liu; Karl T Kelsey
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

8.  Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.

Authors:  Mariana Ferreira Leal; Eleonidas Moura Lima; Patrícia Natália Oliveira Silva; Paulo Pimentel Assumpção; Danielle Queiroz Calcagno; Spencer Luiz Marques Payão; Rommel Rodríguez Burbano; Marília Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review.

Authors:  A Al-Kaabi; L W van Bockel; A J Pothen; S M Willems
Journal:  Dis Markers       Date:  2014-04-07       Impact factor: 3.434

View more
  6 in total

Review 1.  Molecular Research on Oral Diseases and Related Biomaterials: A Journey from Oral Cell Models to Advanced Regenerative Perspectives.

Authors:  Thorsten Steinberg; Martin Philipp Dieterle; Pascal Tomakidi
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 2.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

3.  Prevalence and association of Epstein-Barr virus infection with sinonasal inverted papilloma and sinonasal squamous cell carcinoma in the northeastern Thai population.

Authors:  Thawaree Nukpook; Tipaya Ekalaksananan; Watchareporn Teeramatwanich; Natcha Patarapadungkit; Surachat Chaiwiriyakul; Patravoot Vatanasapt; Sirinart Aromseree; Chamsai Pientong
Journal:  Infect Agent Cancer       Date:  2020-06-24       Impact factor: 2.965

4.  Analysis of DNA methylation of E-cadherin and p16ink4a in oral lichen planus/oral lichenoid lesions.

Authors:  Takatoshi Chujo; Koki Yoshida; Rie Takai; Osamu Uehara; Hirofumi Matsuoka; Tetsuro Morikawa; Jun Sato; Itsuo Chiba; Kenichi Matsuzaka; Yoshihiro Abiko
Journal:  Clin Exp Dent Res       Date:  2020-12-03

5.  Andrographolide Inhibits Epstein-Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins.

Authors:  Praphatson Malat; Tipaya Ekalaksananan; Chukkris Heawchaiyaphum; Supawadee Suebsasana; Sittiruk Roytrakul; Yodying Yingchutrakul; Chamsai Pientong
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

6.  Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.

Authors:  Enrico Tiacci; Stefano Lazzi; Lucia Mundo; Leonardo Del Porro; Massimo Granai; Maria Chiara Siciliano; Virginia Mancini; Raffaella Santi; Lynnette Marcar; Katerina Vrzalikova; Federica Vergoni; Gioia Di Stefano; Gianluca Schiavoni; Giovanna Segreto; Noel Onyango; Joshua Akelo Nyagol; Teresa Amato; Cristiana Bellan; Ioannis Anagnostopoulos; Brunangelo Falini; Lorenzo Leoncini
Journal:  Mod Pathol       Date:  2020-06-01       Impact factor: 7.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.